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Changes in left ventricular volume after a first myocardial 
infarction were studied in 50 patients. Serial radionuclide 
angiograms were obtained 48 h, 10 days and 1 and 6 
months after infarction and left ventricular volume mea- 
sured by a nongeometric method. Left ventricular dilation 
(220% increase in end-diastolic volbme) occurred withhi 
10 days of infarction in 11 patients, who had a mean volume 
increase of 34 f 15% (p = 0.002 versus 48 h) at 10 days and 
61 + 43% (p = 0.01 versus 10 days) at 6 months. Ten other 
patients manifested left ventricular dilation between 10 
days and 6 months with a lesser volume increase of 42 f 
18% by 6 months. 
Among the 21 patients with ventricular dilation, pro- 
gressive dilation (serial volume increases 220% on two or 
more occasions) occurred in 8 patients, who all had a large 
anterior infarct. Mean volume increases at 10 days and 1 
and 6 months were 27 -C 20%, 49 f 40% (p = 0.03 versus 
10 days) and 79 f 37% (p = 0.006 versus 1 month), 
respectively, in this group. In patients with progressive 
dilation, left ventricular ejection fraction decreased from 35 
+ 6% at 48 h to 24 + 10% at 1 month (p < 0.001) and 27 
2 10% (p = 0.006) at 6 months. Between 1 month and 2 
years after infarction six patients died, of whom four had 
ptogressive dilation. 
Severe left ventricular dilation can develop within the 
first 10 days after infarction and may progress during the 
next 6 months, with deterioration in ventricular function 
and a high likelihood of death. 
(J Am Co11 Cardiol1989;13:304-10) 
Left ventricular dilation and impaired ventricular function 
convey a poor prognosis after myocardial infarction (l-5). 
Dilation of the infarct zone may appear within the first few 
days (6,7), reflecting early infarct expansion (8). Subse- 
quently, remodeling of the entire left ventricle may ensue 
with lengthening of both the infarcted and nonihfarcted 
regions (9,lO). The remodeling process may be associated 
with global dilation of the left ventricle and appears to 
represent a compensatory mechanism for maintenance of 
ventricular stroke volume after infarction. Ventricular dila- 
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tion is most frequent in patients with a large infarct and those 
with persistent occlusion of the ihfarct-related artery (11). 
An important question is whether this process of ventric- 
ular dilation eventually compensates for the impairment of 
ventricular function after infarction, and dilation therefore 
stabilizes, or whether compensation fails to occur in some 
patients so that dilation continues for a prolonged period. 
Although several studies of changes in left ventricular vol- 
ume early after infarction are available (6,7,10,1 l), less is 
known regarding the long-term changes. One study (12) of 
changes in ventricular volume in patients given thrombolytic 
therapy after infarction indicated that cjilafion may appear 
late after infarction. Echocardiographic evidence indicates 
that slow expansion oi both the infarct and noninfarct zones 
may continue for many months after infarction (9). 
Experimental studies show that treatment with angioten- 
sin-converting enzyme inhibitors can reduce ventricular 
dilation (13) and improve survival after infarction (14). Initial 
studies (15) in humans also indicate that similar therapy may 
attenuate ventricular dilation after myocardial infarction. 
Further clarification of the natural history of postinfarction 
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left ventricular dilation in humans, therefore, is desirable to 
evaluate the possible benefits of such interventions. 
This study prospectively examined changes in left ven- 
tricular volume during the 6 months after myocardial infarc- 
tion to determine the time course of ventricular dilation. 
Particular attention was given to assessing the time of onset 
of dilation and determining whether dilation was progres- 
sive. Patients were then followed up for 2 years to compare 
the clinical outcome of progressive ventricular dilation with 
that of stabilized left ventricular volume. 
Methods 
Study group. Patients admitted to the coronary care unit 
with a first myocardial infarction were assessed for inclusion 
in the study. At the time of this study, thrombolytic therapy 
was not routinely administered in our institution and those 
patients who received thrombolytic therapy during clinical 
trials were not included in the study. The study group thus 
allowed a prospective study of the natural history of left 
ventricular vo!ume changes after infarction. Patients with 
concurrent valvular or cardiomyopathic disease, atrial fibril- 
lation or age >70 years were excluded. Patients with evi- 
dence of mitral regurgitation due to papillary muscle dys- 
function were also excluded. If a radionuclide angiogram 
could not be performed within 48 h of infarction, the patient 
was excluded. The study protocol was approved by the 
hospital ethics and review committee and all patients gave 
informed consent to participate. 
Study protocol. For each patient, the diagnosis of myo- 
cardial infarction was confirmed by the presence of chest 
pain, new Q waves or persistent ischemic T wave changes on 
the electrocardiogram (ECG), and a rise in plasma creatine 
kinase to at least twice the upper limit of normal (I50 U/liter) 
with a significant MB fraction (>6%) on two occasions. 
Plasma creatine kinase was measured every 8 h to peak 
levels, then daily until it returned to normal. Patients with 
recurrent chest pain and a secondary rise in plasma creatine 
kinase, consistent with reinfarction, were excluded. Cardiac 
catheterization was performed on 33 patients (18 with ante- 
rior and 15 with inferior infarction) during the convalescent 
period, and contrast ventriculography in the right anterior 
oblique projection confirmed absence of mitral regurgitation. 
Each patient’s clinical course was followed at clinic 
visits, 1 and 6 months after infarction. During the next 2 
years, patients were followed up in the clinic or by local 
practitioners. Information gathered from clinical records and 
telephone interviews with patients and local practitioners 
was recorded in a computerized data retrieval system. 
Cardiac mortality was defined as sudden death (within I h of 
cardiac symptoms) or death from reinfarction or refractory 
cardiac failure. 
Measurement of left ventricular volume. Equilibrium 
radionuclide angiograms were performed within 48 h of 
infarction and repeated at 10 days and I and 6 months after 
infarction. The patient’s erythrocytes were labeled “in 
vivo” with an initial intravenous injection in the right arm of 
10 pg/kg body weight of stannous pyrophosphate (Mallinck- 
rodt) followed after IO min with I5 mCi technetium-99m 
pertechnetate (16). The angiogram was acquired with the use 
of a gamma camera with a high sensitivity slant-hole colli- 
mator (Sigma 420, Ohio Nuclear). The patient was supine 
and the collimator aligned in a 30” left anterior oblique 
position with slant holes directed caudally. Radionuclide 
counts were collected for 6 min. with use of a matrix size of 
64 x 64 pixels with the cardiac cycle gated into 24 frames 
(D@ital Equipment Co., Gamma II). 
Immediately after scanning, a 5 ml venous blood sample 
was collected from the left arm. This sample was weighed 
and counted at I5 cm above the same collimator for 2 min to 
determine the count rate per milliliter of blood. All radionu- 
elide data analysis was performed by experienced nuclear 
medicine technicians who were unaware of the patient’s 
clinical status. The left ventricular blood pool at end-diastole 
and end-systole was defined by an edge-detection algorithim 
(17) with manual modification by the operator if necessary. 
Noncardiac radionuclide activity was measured in a back- 
ground region lateral to the end-systolic blood pool. 
Lqft ~.entric’ulcir ~dume b4ws cdcrrluted wiih u nongeo- 
metric counts-based technique (18.19). The background- 
corrected count rate in the left ventricular blood pool at 
end-diastole was normalized to the count rate per milliliter of 
peripheral venous blood with a correction for radionuclide 
decay: 
LVEDVrn = left ventricular end-diastolic count rate 
(count rate/ml blood) x e0 w’~” ’ 
where LVEDVrn = radionuclide left ventricular end- 
diastolic volume; t = time in minutes from the midpoint of 
the scan to counting of the peripheral blood sample: and 
e”.0”“)25’ = decay rate of technetium-99m activity. 
The radionuclide volume measurement is less than the 
true left ventricular volume measurement because of tissue 
attenuation of the technetium-99m photon activity (20). 
Because this study examined changes in left ventricular 
volume in individual patients, correction for tissue attenua- 
tion was not employed, but each patient served as his or her 
own control. Each patient’s initial left ventricular end- 
diastolic volume measurement was normalized to 100 U and 
subsequent volumes expressed relative to this initial volume. 
Normalized left ventricular stroke volume was also calcu- 
lated as the product of ejection fraction and left ventricular 
end-diastolic volume at each study. The reproducibility of 
serial nongeometric radionuclide measurements of left ven- 
tricular volume has been evaluated in two previous studies 
(I I ,20), and the variation in sequential volume measure- 
ments is ~20%. Accordingly, left ventricular dilation was 
defined as an increase in left ventricular end-diastolic vol- 
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Table 1. Characteristics of Patient Groups (n = 50) According 
to Change in Left Ventricular Volume During the 6 Months 
After Infarction 
Left Ventricular Volume 
Increase Stable Decrease 
Age (yr) 56 +8 55 ?I 56 *I 
Men 18 17 7 
Women 3 4 I 
Anterior MI 12 12 5 
Inferior Ml 9 9 3 
Peak CK (U/liter) 2,539 ? 1,468 1,741 f 983 1,418 t 921 
(mean ? SD) 
MI = myocardial infarction; CK = plasma creatine kinase 
ume of ~20% relative to the initial volume. Progressive 
dilation was defined as an initial increase in volume of ~20% 
with an additional increase ~20% on a subsequent occasion. 
Patients with an initial volume increase ~20% but no addi- 
tional increase ~20% on later studies were regarded as 
having stabilized dilation. 
Statistical analysis. Patient characteristics were com- 
pared between groups by an unpaired t test. Serial changes 
in left ventricular volume and ejection fraction were com- 
pared within groups by repeated analysis of variance mea- 
sures (21). The relation between change in volume and 
ejection fraction during the 6 months after infarction was 
determined by linear regression analysis. Results are ex- 
pressed as mean ? SD and a p value ~0.05 is regarded as 
significant. 
Results 
Patient characteristics. Fifty-three patients were admit- 
ted to the study, of whom 3 died before 10 days and had no 
second radionuclide angiogram. The remaining 50 patients 
(42 men and 8 women with a mean age of 55 2 7 years) 
formed the study group. Twenty-nine patients had an ante- 
rior infarct, of whom 3 had a non-Q wave infarct, and 21 had 
an inferior infarct, of whom 4 had a non-Q wave infarct. 
Between 10 days and 1 month after infarction, 4 patients died 
and another 3 patients died between 1 and 6 months. All 43 
survivors underwent repeat radionuclide angiography at 6 
months. 
Left ventricular volume (Table 1). During the 6 months 
after infarction, 21 patients manifested 220% left ventricular 
dilation. In contrast, 8 patients had a decrease in left 
ventricular volume 220% during the 6 months after infarc- 
tion, while the remaining 21 patients had ~20% change in left 
ventricular volume. The characteristics of the 21 patients 
with left ventricular dilation are compared with those of the 
29 patients with stable or decreasing volume in Table 1. 
There were no differences in gender or age distribution 
between the groups. Among the 29 patients tith an anterior 
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Figure 1. Time course of changes in left ventricular end-diastolic 
volume. Patients are grouped according to whether an increase in 
volume Z-20%, a decrease in volume ~20% or a ~20% change 
(stable) occurred during the 6 months after myocardial infarction 
(mean * SD; 10 days n = 50, 30 days n = 46, 180 days n = 43). 
infarct, 12 developed left ventricular dilation, compared with 
9 of 21 patients with an inferior infarct. No patient with a 
non-Q wave infarct developed ventricular dilation. Patients 
with dilation had higher peak creatine kinase levels than did 
those without dilation, but the difference was not significant. 
Early versus late left ventricular dilation. The time course 
of changes in left ventricular end-diastolic volume for pa- 
tients who survived to 6 months is shown in Figure 1. In 
patients with a stable left ventricular volume during the 1st 
month after infarction, volume remained unchanged at 6 
months. Similarly, in patients who had a decrease in left 
ventricular volume during the 1st month, volume also re- 
mained stable between 1 and 6 months. In contrast, the 
group with left ventricular dilation displayed a progressive 
increase in left ventricular volume of 25.5 2 24% at 10 days, 
40.8 + 47.1% at 1 month and 51.4 2 33% at 6 months. 
Among the 21 patients developing left ventricular dila- 
tjon, 11 manifested early dilation within 10 days of infarc- 
tion. Nine of these patients survived to 6 months; the two 
who died had a large left ventricular volume increase (56% 
and 200%, respectively) before death. The patients with 
early dilation had a large initial volume increase of 34.4 IfI 
14.6% by 10 days (p = 0.002 versus volume on admission). 
The dilation progressed to a mean volume increase of 60.7 k 
42.5% at 6 months (p = 0.01 versus 10 days). Ten patients 
did not manifest dilation until >lO days after infarction and 
nine of these patients survived to 6 months. The mean 
volume increases in this group at 1 and 6 months were 17.4 
? 19.1% (p = 0.019 versus admission volume) and 42.1 * 
17.9% (p = 0.002 versus volume at 1 month), respectively. 
Progressive versus stable dilation. Left ventricular dila- 
tion was progressive in 8 of the 21 patients who had a volume 
increase ~-20%. Five of these patients had early dilation 
within 10 days of infarction and 3 had later dilation (Fig. 2). 
In the seven patients with progressive dilation who survived 
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Figure 2. Comparison of left ventricular end-diastolic volume in 
patients with progressive ventricular dilation and those with stabi- 
lized dilation. Data are shown for the 7 patients with progressive 
dilation and 11 with stabilized dilation who survived for 6 months 
(meaq + SD; *p < 0.02 versus admission volume; **p < 0.05 versus 
volume at IO days; ***p < 0.03 versus volume at 30 days). 
6 months, the mean volume increase at 10 days was 26.9 2 
20% (p = 0.011 versus admission volume), increasing to 79.4 
3- 37% at 6 months (p = 0.006 versus volume at 1 month). 
Not shown in Figure 2 is one patient who had an increase in 
left ventricular end-diastolic volume of 93% at 10 days and 
200% at I month and who died before 6 months. 
The other 13 patients did not meet the criteria for 
progressive dilation nnd this group displayed smuller 
changes in volume. In this group with stabilized dilation, I I 
patients survived to 6 months, having volume increases of 
17.8 t 15.6% at 10 days, 21.4 t 16.3% at I month (p = NS 
versus volume at 10 days) and 33.5 2 11.5% at 6 months (p 
= 0.03 versus volume at 10 days) (Fig. 2). The two patients 
who died before 6 months had the greatest dilation in this 
group (volume increases of 56% and 41%, respectively, 
during the 1st month after infarction). All eight patients with 
progressive dilation had an anterior infarct and had higher 
peak creatine kinase levels (3,737 +- 1,162 U/liter) than did 
patients with stabilized dilation (2,742 2 1,770 U/liter (p = 
NS). 
Left ventricular ejection fraction. The patients who had a 
stable left ventricular volume had an admission ejection 
fraction of 47.8 t 7.5%, which increased to 54.4 ? 8.9% (p 
= 0.029) by 6 months (Fig. 3, top panel). Similarly, patients 
who had a decrease in volume had an increase in ejection 
fraction from 47.1 2 6.9% at admission to 54.4 2 7.5% (p = 
0.025) at 6 months after infarction. Among patients with 
stable dilation, left ventricular ejection fraction was un- 
changed from 46.3 +- 15.2% at admission to 46.0 ? 14.2% at 
6 months (Fig. 3, bottom panel). In contrast, the patients 
with progressive dilation had the lowest admission ejection 
fraction (35.0 t 6.4%), which decreased further by 1 month 
(23.7 f 10.2%, p < 0.001) and 6 months (26.9 L 9.7%, p = 
0.006 versus admission value). Ejection fraction at 6 months 
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Figure 3. Ejection fraction after myocardial infarction. Top panel, 
Changes in left ventricular ejection fraction in patients with stable (n 
= 17) or decreasing (n = 8) ventricular volume during the 6 months 
after infarction (mean rfr SD, *p < 0.05 versus admission value). 
Bottom panel, Comparison of ejection fraction in patients with left 
ventricular dilation according to whether dilation is progressive (n = 
7) or stabilized (n = I I) (mean t SD, *p < 0.01 versus admission 
value: **p < 0.05 versus progressive dilation). 
inversely reflected changes in left ventricular volume (Fig. 
4). 
Stroke volume and heart rate. Changes in normalized left 
ventricular stroke volume are compared between patients 
with stable ventricular volume and those with ventricular 
dilation in Figure 5. Among those with stable left ventricular 
Figure 4. Inverse relation between left ventricular volume change 
and ejection fraction in 43 patients at 6 months after infarction. 
y=-0.25x + 52.5 
r=-0.67 
SEE= 10.6 
CHANGE IN LEFT VENTRICULAR VOLUME AT 6 MONTHS (%) 
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Figure 5. Comparison of normalized left ventricular stroke volume 
in patients with progressive ventricular dilation, those with stabi- 
lized dilation and those without dilation in the 6 months after 
infarction (mean ? SD, *p < 0.05 versus admission value). 
end-diastolic volume, stroke volume increased from 47.8 ‘- 
7.5 U at admission to 55.4 ? 11.7 U at 6 months (p = 0.048). 
Heart rate at admission (76 2 12 beatslmin) was unchanged 
at 6 months (72 + 14 beats/min). Similarly, in those patients 
with dilation and subsequent stabilization of ventricular 
volume, stroke volume increased from 45.3 2 13.7 U at 
admission to 59.6 t 20 U at 6 months (p < 0.01) and heart 
rate was (72 ? 11 beatslmin) at admission and (75 2 13 beats/ 
miil) at 6 months. In contrast, patients with progressive 
dilation had the lowest admission stroke volume (33. I f 7.9 
U), which increased to 46.4 + 11.5 U at 6 months (p < O.Ol), 
but remained less than the stroke volume of patients with 
stable left ventricular volumes or stabilized dilation. This 
group had a decrease in heart rate between admission (93 it_ 
12 beats/min) and 6 months (73 ? 15 beats/min, p < 0.05). 
There were no differences in mean arterial pressure between 
patients with left ventricular dilation and those with stable 
ventricular volumes. 
Clinical course. No patients were lost to follow-up during 
the 2 years after infarction. Four of the 50 patients died 
between 10 days and 1 month, each of whom had a large 
anterior infarct and severe cardiac failure. One of these 
patients had an increase in left ventricular end-diastolic 
volume of 56% by 10 days and died at 3 weeks. The other 
three patients had ~20% change in volume by IO days but 
died of ventricular fibrillation or cardiogenic shock at 12 to 
15 days. 
Subsequently, three patients died between I and 6 
months, of whom two had left ventricular dilation (including 
one with progressive dilation). One patient had a volume 
increase of 200% and developed left bundle branch block, 
whereas another had a volume increase of 41% before death. 
The remaining patient died suddenly at 6 weeks, having a 
volume increase of only 13%. Three additional patients died 
between 6 months and 2 years after infarction. Each of these 
patients had developed progressive left ventricular dilation 
with volume increases of 62%, 76% and 150% at 6 months 
after infarction. Therefore, of 10 patients who died during 
the 2 years after infarction, 6 had left ventricular dilation. 
Among the eight patients with progressive ventricular dila- 
tion, four died within 2 years of infarction. 
Tw putients were d&nosed as having left ventricular 
nnewysms hy 6 months on the basis of ancillary investiga- 
tions including echocardiography and contrast ventriculo- 
graphy. Both of these patients were in the progressive 
dilation group. Three patients with progressive left ventric- 
ular dilation required antiarrhythmic therapy for recurrent 
ventricular tachycardia after hospital discharge, of whom 
two later died. Among the eight patients with progressive 
dilation, seven required diuretic therapy for clinical cardiac 
failure, compared with only two of the patients with stabi- 
lized dilation. Three patients with progressive dilation also 
received treatment with angiotensin-converting enzyme in- 
hibitors between 1 and 6 months after infarction. In contrast, 
none of the patients with stable or decreasing volumes 
manifested cardiac failure and none required diuretics or 
angiotensin-converting enzyme inhibitors. There was no 
difference in nitrate usage between patients with and without 
dilation. None of the patients who had progressive dilation 
received a beta-adrenergic blocking agent or calcium chan- 
nel antagonists. Coronary revascularization (angioplasty or 
saphenous vein grafting) was performed within 6 months of 
infarction in three patients with and four patients without 
dilation. 
Discussion 
This study shows that severe global left ventricular dila- 
tion can occur within 10 days of myocardial infarction, and 
approximately 40% of infarct survivors will develop ventric- 
ular dilation within 6 months of infarction. In patients 
developing ventricular dilation, nearly 40% have progressive 
dilation. This progressive dilation is associated with continu- 
ing deterioration in left ventricular function and increased 
two-year mortality. In contrast, patients with dilation that 
stabilizes during the 6 months after infarction have a better 
clinical outcome. 
Initiation of ventricular dilation. Several factors may 
contribute to changes in left ventricular volume after infarc- 
tion, including infarct size, infarct expansion, persistent 
occlusion of the infarct-related artery and myocardial dys- 
function due to reversible ischemia. This study and others 
(6, I I) have shown that ventricular volume may decrease and 
ejection fraction increase during the weeks after infarction in 
some patients. This improvement probably reflects return of 
contractility to postischemic myocardium, a possibility sup- 
ported by the relation between patent infarct-related arteries 
and later improvement in ventricular function (1 I ,22,23). 
The major initial volume increase observed in patients 
with early dilation is most likely due to lengthening of the 
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infarct region. The greatest risk of infarct expansion, with 
myocyte slippage and lengthening of the infarct segment, 
occurs between 3 and 10 days after infarction (8,24,25). All 
the patients with early dilation had a large, Q wave infarct, 
which is a known predisposing factor for infarct expansion. 
Persistent occlusion of the infarct-related artery is associ- 
ated with ventricular dilation (I 1) and aneurysm formation 
(22). Such persistent occlusion may result in a larger infarct 
and transmural necrosis with increased risk of infarct expan- 
sion. 
Mechanism of continuing dilation. In contrast to early 
dilation, which appears to be primarily due to lengthening of 
the infarct region, studies of experimental infarction (24-26) 
have shown that later dilation of the left ventricular cavity is 
associated with lengthening of both the infarcted and nonin- 
farcted segments. Echocardiographic studies (9,lO) in hu- 
mans have also documented dilation of the noninfarcted 
region during the convalescent phase of infarction. Several 
studies (10,271 have indicated that ventricular wall stress is 
increased in both infarcted and noninfarcted regions as a 
result of such dilation. This increased wall stress can result 
in eccentric hypertrophy of the noninfarcted myocardium 
(28-30). These changes in left ventricular volume and wall 
thickness appear to represent a compensatory mechanism to 
maintain cardiac output after infarction (IO). 
The c%unges in left ventric.ulur volume documented in the 
present study het#~een 10 days und 6 months ufter infarction 
ure consistent with this remodeling hypothesis. Thus, pa- 
tients who developed left ventricular dilation had a lower 
initial ejection fraction and left ventricular stroke volume 
than did those with a stable ventricular volume. The subse- 
quent left ventricular dilation was then associated with a 
restoration of left ventricular stroke volume. An important 
finding, however, is the difference between those patients in 
whom dilation stabilizes and those in whom it progresses. 
Patients with stabilized dilation had a return of stroke 
volume to the same levels as those of patients without 
dilation. Thus, the remodeling process in these patients 
appears to have compensated for the contractile impairment 
due to the infarct. Only mild dilation appeared to be required 
for compensation of stroke volume in this group. 
In contrust, patients with progressive dilution hmve u 
decwusr in ejection fruction and their stroke volume does 
not catch up with that of other postinfarction patients. 
Despite severe left ventricular dilation, and presumably 
extensive ventricular remodeling, these patients remain un- 
compensated. It is uncertain why compensation fails to 
occur in these patients, but possible mechanisms include an 
infarct region that is simply too large for remodeling to 
restore favorable ventricular geometry, or a rate of cavity 
dilation that exceeds the rate of eccentric myocardial hyper- 
trophy, resulting in reduced systolic tension development. 
Another factor may be late deterioration in contractility of 
the remaining hypertrophied, noninfarcted myocardium 
(29,30). 
Ventricular dilation and prognosis: role of therapy. The 
adverse effect of cardiac enlargement was demonstrated in 
early studies of postinfarction prognosis. More recently, left 
ventricular dilation has been shown to confer an added risk 
of late sudden death in patients with impaired left ventricular 
function (5). The present study. although limited in size. 
does suggest that it is the patient with progressive dilation 
who is at greatest risk of late death after infarction. The high 
mortality and morbidity associated with left ventricular 
dilation after infarction indicate a need to identify these 
patients. Our study shows that patients at risk for developing 
severe dilation, such as those with a large anterior infarct. 
will frequently manifest early significant dilation that can be 
detected by echocardiography or radionuclide angiography 
during the hospitalization period. 
In \icwp of the rclrrtion het#wn occltr.vinn of’thc injhrct- 
reluted urtery und ~~rntriculur dilution (I I, IS), thrombolytic 
therapy may decrease the risk of ventricular dilation by 
reducing infarct size or preserving a rim of epicardium and 
reducing infarct expansion. Although experimental studies 
(31) indicate a beneficial effect of thrombolysis on infarct 
expansion, one recent study ( 12) found no difference in late 
left ventricular volume between patients with successful and 
unsuccessful thrombolysis. Studies (15) with the angioten- 
sin-converting enzyme inhibitor, captopril, also offer prom- 
ise of attenuation of ventricular dilation after infarction. The 
patterns of ventricular dilation documented in this study 
offer a reference against which the benefit or lack of benefit 
of future therapeutic measures could be evaluated. 
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